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Abstract 
In order to investigate the effect of using different solid state forms and specific surface area 
(TBET) of active pharmaceutical ingredients on tabletability and dissolution performance, the mono- and 
dihydrated crystalline forms of chlorothiazide sodium and chlorothiazide potassium (CTZK) salts were 
compared to alternative anhydrous and amorphous forms, as well as to amorphous microparticles of 
chlorothiazide sodium and potassium which were produced by spray drying and had a large specific 
surface area. The tablet hardness and tensile strength, porosity and specific surface area of single-
component, convex tablets prepared at different compression pressures were characterised.  
Results confirmed the complexity of the compressibility mechanisms. In general it may be 
concluded that factors such as solid-state form (crystalline vs. amorphous), type of hydration (presence 
of interstitial molecules of water, dehydrates) or specific surface area of the material have a direct 
impact on the tabletability of the powder.  
It was observed that, for powders of the same solid state form, those with a larger specific 
surface area compacted well, and better than powders of a lower surface area, even at relatively low 
compression pressures. Compacts prepared at lower compression pressures from high surface area 
porous microparticles presented the shortest times to dissolve, when compared with compacts made of 
equivalent materials, which had to be compressed at higher compression pressures in order to obtain 
satisfactory compacts. Therefore, NPMP materials may be considered as suitable for direct compaction 
and possibly for inclusion in tablet formulations as bulking agents, APIs, carriers or binders due to their 
good compactibility performance. 
 Keywords: solid state form, micromeritic characterisation, tabletability, dissolution 
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1. Introduction 
The tabletability, defined as the capacity of powdered material to be transformed into a tablet of 
specified strength under the effect of compression pressure1, and the dissolution performance of an 
active pharmaceutical ingredient (API) in a solid dosage form may be tuned by the appropriate use of 
excipient materials in the formulation2. However, the possibility of using excipients such as fillers, 
binders, disintegrators, lubricants, solubility enhancers etc. may be limited in the case of high-dose 
APIs, due to the potentially large size of the final solid dosage form. In such cases the characteristics of 
the API have obvious importance and it is vital to assess the tabletability and dissolution performance 
of the API in the preformulation stage of product development.  
Chlorothiazide is an example of a high dose (single oral dose: 250 mg or 500 mg), poorly water 
soluble API (solubility of approximately 0.2 mg/ml in water), with a very high melting point  
of 363 °C 3. Chlorothiazide (CTZ) can form hydrophilic sodium (CTZNa) and potassium (CTZK) salts, 
that exist in both hydrated and anhydrous forms3,4. The amorphous form of chlorothiazide is difficult to 
produce, is physically unstable and prone to fast recrystallisation5,6. In contrast, sodium and potassium 
salts readily form amorphous forms on spray drying from solution, these forms being characterised by 
high-glass transition temperatures (Tg) of 192 °C (CTZNa) and 159 °C (CTZK)7,8. In a recent study we 
reported on the impact of specific surface area (TBET) of nanocrystalline microparticles (NCMPs) of 
chlorothiazide, produced by spray drying on the tabletability performance of this poorly compactible 
API6. Tabletability of NCMPs was bench-marked against the reference material Di-PacTM, as it is an 
excipient which is known to be a ready to-use direct compression base.  
Chlorothiazide sodium and potassium salts processed by spray drying, in contrast to the parent 
compound, form amorphous (as opposed to crystalline) nanoparticulate microparticles (NPMPs) that 
are characterised by a high specific surface area (i.e. large TBET) of respectively 70 m2/g and 90 m2/g7,8.  
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Nanoparticulate microparticles of trehalose and raffinose were previously produced and reported by Ní 
Ógáin et al. (2011)9. The term NPMP refers to micron-size spheroidal particles composed of nano-sized 
particles, which self-assemble on spray drying.  
Given that chlorothiazide salt forms can be prepared in a number of different solid states, they provide 
a good model for comparative tabletability and dissolution studies.  
Several factors that control powder compactibility have been reported to date. These factors can 
be organised into three main groups: particle mechanics, particle dimensions and particle adhesiveness. 
The most commonly reported relationships include an increase in tablet hardness with a decrease in 
powder particle size and greater tablet hardness as a result of greater particle shape irregularity10.  
In contrast, reports on the effect on tabletability of material solid state characteristics are scarce. Such 
solid state characteristics might include the hydration state of the material, polymorphic form or 
amorphousness/crystallinity.  For example, a study on the influence of the crystal shape on tabletability 
of L-lysine monohydrochloride dihydrate indicated that plate-shaped crystals formed stronger and more 
porous tablets in comparison to prismoidal crystals, though the effect of dehydration was not studied11. 
Compressed orthorhombic crystals of paracetamol, compared to the monoclinic form, exhibited greater 
fragmentation at low pressure, increased plastic deformation at higher pressure, and lower elastic 
recovery during decompression1. It was concluded, from the crystal structure, that sliding planes are 
present in the orthorhombic form, which could be responsible for an increase in crystal plasticity. 
Maggi et al. described the tabletability of α-cyclodextrin (α-CD) hexahydrate batches in comparison to 
a nonstochiometric α-CD·7.57H2O form III and also partially dehydrated and amorphous forms12. 
Amorphous α-CD samples (different batches) displayed the most suitable technological properties for 
use as pharmaceutical adjuvants in tableting processes, in terms of bulk and tapped density, 
compressibility (ability of the material to be reduced in volume as a result of applied pressure1), volume 
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reduction of powders, tensile strength, porosity and disintegration time of compressed tablets (produced 
at five different force levels, from 50 to 300 kN).  A similar study by Pande and Shangraw reported a 
reduced compactibility (ability of the material to produce tablets of sufficient strength under the effect 
of densification1) performance of β-cyclodextrin due to dehydration13.  
Trasi et al. reported that drying, and as a consequence dehydration, of glucose at high temperatures 
promoted the formation of amorphous regions within the particulates which were responsible for better 
compacting properties of processed glucose14. Sebhatu and Alderborn published a study on the 
relationships between the effective interparticulate contact area and the tensile strength of tablets made 
of amorphous (milled) and crystalline lactose of varying particle size15. Amorphous lactose produced 
tablets of higher tensile strength than crystalline lactose and there was a tendency for reduced particle 
size to increase tablet hardness. The results indicated that the differences in compactibility between 
amorphous and crystalline lactose are mainly the result of differences in bonding capacity, although 
differences in particle deformability also play a limited role. 
Di Martino et al., presented a method to improve tabletability of crystalline acetazolamide by spray 
drying16. The study demonstrated that spray drying resulted in improved compressibility for 
acetazolamide, allowing for direct compression of the spray dried material, which could not be 
achieved with powder comprising either pure polymorph I or II. The authors attributed the improved 
compressibility of the spray dried material, which comprised a mixture of the two polymorphs, to 
greater particle rearrangement in the initial stage of compression due to its spherical habit and slightly 
wrinkled texture of the particle surface, favouring interparticulate bond formation. 
While reports in the literature have focused on particle characteristics such as size, mechanics and 
adhesiveness, the impact of another physical property, namely surface area, has received less attention, 
with a limited number of reports investigating the impact of powder surface area on tabletability. 
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Westermarck et al., investigated the pore structure and TBET of mannitol powder, granules and tablets 
and found that, the greater TBET, more porous structure and the presence of a greater number of small 
pores resulted in increased compactibility of mannitol granules compared to mannitol powder17. Plastic 
deformation and fragmentation of powder and granules in compression were observed. The TBET of 
tablets, measured by the nitrogen gas adsorption method provided a good indicator of deformation 
under compression. Fragmentation increased the TBET of the powder, and plastic deformation decreased 
the TBET of granules. Busignies et al. investigated changes in the TBET of tablets made of microcrystalline 
cellulose, lactose and anhydrous calcium phosphate18. Tablets made of microcrystalline cellulose 
underwent plastic deformation, indicated by a reduction of TBET under increased pressure. The TBET of 
lactose tablets was found to decrease as compaction pressure was increased over 150 MPa. The TBET of 
anhydrous calcium phosphate tablets increased regardless of the compaction pressure applied. The 
evolution of the TBET correlated with the tensile strength of the corresponding tablets.  
The present work evaluates the compactibility performance of amorphous, anhydrous 
nanoparticulate microparticles (NPMPs) of chlorothiazide sodium (CTZNa) and potassium (CTZK) in 
comparison to dihydrated CTZNa and CTZK (CTZNa DH, CTZK DH), anhydrous CTZNa and CTZK 
(CTZNa ANH, CTZK ANH), anhydrous amorphous spray dried microparticles (CTZNa MP, CTZK 
MP) and in comparison to Di-PacTM- a sugar-based direct compression excipient (Table 1). The 
manuscript underlines the impact of relatively high specific surface area of the previously described 
NPMPs7,8 on tabletability performance. Selected tablets are subjected to dissolution test studies in order 
to evaluate potential advantages of the use of NPMPs in final solid dosage forms.   
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2. Materials and methods  
2.1. Materials 
Materials used in experiments were chlorothiazide (CTZ) (Sigma, Ireland), sodium hydroxide 
(NaOH, Riedel de Haën, Germany), potassium hydroxide (KOH, Merck, Germany). Solvents and other 
reagents: deionised water (Purite Prestige Analyst HP, Purite Limited, UK), methanol and (Sigma, 
Ireland), n-propanol and ethyl acetate (Lab Scan, Ireland), butyl acetate (Merck, Germany), Hydranal-
Composite and hydrochloric acid 32% (Riedel de Haën, Germany), Di-PacTM (Domino Foods Inc., 
Florida, USA).  
2.2. Methods 
2.2.1. Preparation and physicochemical characterisation of different solid state forms of 
chlorothiazide sodium and potassium salts   
Chlorothiazide sodium (CTZNa) dihydrate and potassium (CTZK) dihydrate (DH) and 
anhydrous (ANH) CTZNa were prepared as previously described3,4. CTZK and CTZNa microparticles 
(MP) were obtained by spray drying of 2% w/v salt solution from water using the open mode 
configuration of the Büchi B-290 Mini Spray Dryer (Büchi, Switzerland) followed by secondary tray 
drying at 170 ˚C for 3 hours in an oven (Memmert UL 40, Germany)7. The same method of secondary 
tray drying was applied to dehydrate CTZK DH in order to obtain CTZK ANH. In order to obtain 
CTZK monohydrate (MH) the temperature of secondary drying was reduced to 100 ˚C. 
Spray drying to prepare NPMP chlorothiazide sodium and potassium materials was also performed 
using a Büchi B-290 Mini Spray Dryer (Büchi, Switzerland)7. Spray dried solutions comprised a mixed 
solvent system of methanol and butyl acetate, as previously described7. An inert loop Büchi B-295 (for 
organic solvents) was used for the closed mode operation. A standard atomization nozzle with a 1.5 
mm cap and 0.7 mm tip was employed for each sample. The additional, secondary drying (AD) was 
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performed in an incubator with forced air flow (Gallenkamp economy incubator with fan, Weiss-
Gallenkamp, UK) as previously described7.  
The particle size distributions of chlorothiazide sodium and potassium hydrated forms (CTZNa DH, 
CTZK DH and CTZK MH) and anhydrous forms (CTZNa ANH and CTZK ANH) were brought as 
close as possible to the size of spray dried salts using a mortar and pestle at room temperature and 
ambient relative humidity (RH) (35 to 40% RH), monitored using TestoTM RH and temperature data 
logger. The chemical purity of the produced solid-state forms was assessed using a HPLC method, as 
previously described8.    
Materials used for tableting were comprehensively characterised as previously described7. True density 
(d0) was measured using helium (99.995% purity) with an AccuPyc 1330 Pycnometer (Micromeritics, 
Norcross, GA, USA) and results presented are an average of three measurements. To image particles, a 
Mira Variable Pressure Field Emission Scanning Electron Microscope (SEM) was used. Measurements 
of particle size and particle size distributions were obtained using a laser diffraction particle sizer 
Mastersizer 2000 (Malvern Instruments, UK). Particles were dispersed using a Scirocco dry feeder 
instrument with 2 bar pressure. An obscuration of 0.5-6% was obtained under a vibration feed rate of 
50%; results reported are the average of three analyses. To determine the specific surface area (TBET) by 
the Brunauer, Emmett, Teller (BET) isotherm method, a Micromeritics Gemini VI (Micromeritics, 
Norcross, GA, USA) surface area analyzer was used. The amount of nitrogen adsorbed at 6 relative 
pressure points in the relative pressure (P/P0) range of 0.05 to 0.3, with an equilibration time of 10 s, 
was used for the BET analysis. Each average result is calculated on the basis of three measurements. 
Free space was determined separately for each sample using helium gas. Saturation pressure Po was 
determined prior to the measurement of each sample.  
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2.2.2. Tableting and characterisation of tablets 
Tablets (n=10) were compressed using an experimental, laboratory scale single punch tablet 
press MTCM 1 from GlobePharma (USA) supplied with an Enerpac (USA) AC RC53 piston working 
in the range from 0-7 GPa (max. 5 tons, 45 kN) and standard concave 10 mm diameter punch and die 
tooling. The die was loaded manually with a known weight (Sartorius BP121S balance) of the powder 
(250 mg) and compressed in the range from 21 to 278 MPa, corresponding to the range of compression 
force from 1 to 13 kN. The therapeutic single dose of chlorothiazide is 250 mg and may be doubled. 
This is one of the reasons why the weight of the tablets of chlorothiazide described in a previous study 
was set to the above-mentioned weight6 The tablet weight was maintained at 250 mg for the current 
study to allow for comparisons with previously reported data on chlorothiazide tablets. 
Pressure was released immediately after reaching the desired compression pressure. Tablets were 
pushed out of the die using the bottom punch. To lubricate the tablet press tooling, the die and upper 
punch were dusted, using a paint brush, with magnesium stearate.  
In order to confirm that materials did not undergo solid state transformation upon compression, 
samples of all materials (250 mg) were subjected to compression in a Perkin Elmer hydraulic press 
under 10 tons load for 1 minute. The compacted discs (10 mm diameter) were subjected to PXRD 
analysis, then ground in an agate mortar and tested again using PXRD (data not shown).  
A set of ten tablets prepared on the MTCM 1 tablet press was subjected to radial hardness testing using 
a Dr. Schleuniger, Pharmatron, Model 6D tablet tester. Fracture load (shear strength under compressive 
load) (P)19 [N] was recorded for each tablet (n=10). It was monitored if the tablet capped under the 
applied pressure and if the breakage of the tablet occurred in a consistent manner.  
The tensile strength of the materials (σt) was calculated using an expanded empirical model for convex 
tablets19,20: equation 1.  
 
 
 9 
𝜎" = $%&'()* ∙ 1/ ..0(1.) − %.$.314 + 6.$74.) + 0.01    Eqn. 1. 
Tablet porosity was calculated from the true density of the material (d0) and the density of the tablet 
calculated after compaction (dt)12, on the basis of the measured volume. 
The height (H), diameter (2r) and the band thickness (h) of the tablets were recorded (n=10) using an 
electronic outside micrometer IP 54 form RS (0-25 mm ±0.001 mm) equipped with ABS- anti crushing 
system.  Measured geometric parameters of the tablet allowed the volume of the tablet (Vt)  to be 
calculated using equation 2 21. 
Height of the tablet (H) equals to sum of band thickness (h) and height of the tablet caps (hc) multiplied 
by 2 (𝐻 = ℎ + 2ℎ<). Therefore: ℎ< = 1=4. . Volume of the caps forming tablet equals to:  𝑉< = '6 3𝑟. + ℎ<. ℎ<. Volume of the cylinder forming tablet equals to: 𝑉<AB. = 𝜋𝑟.ℎ. Therefore, Vt 
equals to:  𝑉" = '6 3𝑟. + ℎ<. ℎ< + 𝜋𝑟.ℎ  Eqn.2. 
Materials used for tableting are listed in Table 1. 
 
Table 1. Description of materials used for tableting studies. 
Abbreviation Description of system 
CTZNa DH Crystalline chlorothiazide sodium dihydrate 
CTZNa ANH Anhydrous chlorothiazide sodium 
CTZNa MP Spray dried nonporous microparticles of amorphous, anhydrous chlorothiazide sodium 
CTZNa NPMP Spray dried nanoparticulate microparticles of amorphous, anhydrous chlorothiazide sodium 
CTZK DH Crystalline chlorothiazide potassium dihydrate 
CTZK MH Particles of crystalline chlorothiazide potassium monohydrate 
CTZK ANH Particles of amorphous chlorothiazide potassium 
CTZK MP Spray dried nonporous microparticles of amorphous, anhydrous chlorothiazide potassium 
CTZK NPMP Spray dried nanoparticulate microparticles of amorphous, anhydrous chlorothiazide potassium 
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Di-PacTM Direct compacting and tableting sugar: 96.5±1.5% sucrose, 3.0±0.75% maltodextrin 
 
 
 
2.2.3. Dissolution studies  
Dissolution studies were performed with a type 2 dissolution test apparatus (VanKel VK7000 
dissolution test station equipped with a VK650 heater/circulator)19. The rotation speed of the paddle was 
set to 50 rpm. 900 ml of degassed phosphate buffer pH 6.819  was used as the dissolution medium, 
equilibrated at 37 ˚C. The dissolution medium was constantly circulated using an LSMatec peristaltic 
pump fitted with a 10 µm cannula filter (HMWPE, Porex Technologies, Germany) through a 2 mm 
flow-through UV cuvette placed in a Cecil CE2020 UV-spectrophotometer set to measure absorbance 
at l=265 nm. The rate of medium circulation was set to 25 ml/min. Presented results are an average of 
at least three measurements. 
 
2.2.4. Statistical analysis of data 
Statistical analysis was carried out using Minitab (State College, PA, USA) software.  
A t-test at a significance level of 0.05 was applied, with a p value of less than 0.05 indicating that the 
observed differences between the means were statistically significant. 
 
3. Results and Discussion 
3.1. Physicochemical characterisation of powders subjected to compaction 
 The crystal structures of the chlorothiazide sodium dihydrate (CTZNa DH) and its alternative 
anhydrous (CTZNa ANH) form were previously described1. The true density and specific surface area, 
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determined by BET analysis (TBET), of all materials are listed in Table 2, while the particle size 
distributions of all materials subjected to tableting are shown in Table 3. HPLC indicated that there was 
no chemical degradation in any of the solid state forms produced by the methods described in section 
2.2.1. As described previously, amorphous materials of chlorothiazide sodium and chlorothiazide 
potassium were physically and chemically stable under long term stability study storage conditions 
(RH ≈0%, 25 °C) for over six months8. After compaction in the IR press (as described in section 
2.2.2.), none of the tested materials showed a change in surface or bulk solid state characteristics in 
comparison to the starting powders. 
  
Table 2. Micromeritic properties of powders which were subjected to compaction (true density (d0), 
specific surface area by BET (TBET), and specific surface area calculated from laser diffraction particle 
size analysis data (TLD) based on surface weighted mean (d[3,2]). Abbreviations as per Table 1.  
Material True density d0 [g/cm3] TBET [m2/g] TLD [m2/g] 
CTZNa DH 1.728±0.004 2.73±0.01 1.41±0.02 
CTZNa ANH 1.883±0.001 3.07±0.01 1.04±0.03 
CTZNa MP 1.837±0.015 1.32±0.04(a) 1.82±0.01 
CTZNa NPMP 1.856±0.001 72.32±0.71(a) 1.81±0.02 
CTZK DH 1.887±0.003 0.62±0.03 0.72±0.04 
CTZK MH 1.859±0.001 1.74±0.03 0.83±0.03 
CTZK ANH 1.881±0.003 1.30±0.02 0.94±0.01 
CTZK MP 1.872±0.003 1.33±0.01(a) 1.61±0.02 
CTZK NPMP 1.863±0.012 90.20±0.91(a) 1.71±0.02 
Di-PacTM 1.554±0.001 0.21±0.04(b) 0.11±0.01 
a) and b) - results consistent with values previously reported6,7. 
 
  
 
 
 12 
Table 3. Particle size distribution parameters of tested powders: 10th percentile particle size (d(10)), 
median particle size (d(50)), 90th percentile particle size (d(90)) and Span: . 
Sample d(10) d(50) d(90) Span Particle size distribution 
CTZNa DH 0.92±0.02 5.44±0.13 53.11±0.10 9.64±0.21 Trimodal 
CTZNa 
ANH 1.31±0.12 6.22±0.32 49.40±0.24 7.70±0.34 Trimodal 
CTZNa MP  1.43±0.21 2.61±0.11(a) 7.24±0.13 1.80±0.10(a) Monomodal 
CTZNa 
NPMP  1.11±0.10 2.93±0.02(a) 6.8±30.22 1.91±0.14(a) Monomodal 
CTZK DH 1.30±0.11 8.73±0.14 58.42±0.22 6.61±0.22 Trimodal 
CTZK MH 1.30±0.23 5.24±0.22 16.82±0.14 3.02±0.12 Bimodal 
CTZK ANH 1.72±0.14 9.70±0.21 113.41±0.32 11.63±0.31 Bimodal 
CTZK MP 1.23±0.12 3.11±0.13(a) 6.64±0.21 1.82±0.23(a) Monomodal 
CTZK 
NPMP 1.03±0.02 3.12±0.13(a) 6.84±0.01 1.91±0.13(a) Monomodal 
Di-PacTM 27.31±0.31 178.44±0.63(b) 398.51±1.22 2.11±0.10 Monomodal 
a) and b) - results consistent with values previously reported6,7. 
 
CTZNa DH had a true density (d0) of 1.728±0.004 g/cm3 compared to a theoretical density, calculated 
based on the single crystal X-ray diffraction data, of 1.836 g/cm3 3. Surface area by BET analysis (TBET) 
of CTZNa DH was measured to be 2.73±0.01 m2/g. In comparison to CTZNa DH, CTZNa ANH which 
was size reduced with a mortar and pestle had a higher d0 of 1.883±0.001 g/cm3, which may be 
attributed to rearrangement of the crystal lattice due to dehydration.  The TBET of this CTZNa ANH 
sample was 3.07±0.01 m2/g.  
 Properties of spray dried systems of CTZNa which were amorphous, anhydrous and consisting 
of nonporous microparticles (CTZNa MP) and CTZNa systems which were amorphous, anhydrous and 
consisting of nanoparticulate microparticles (CTZNa NPMP) were previously described7,8. Both spray 
dried materials, CTZNa MP and CTZNa NPMP, were anhydrous and presented values of true density 
close to that of CTZNa ANH, i.e. 1.837±0.015 g/cm3 and 1.856±0.001 g/cm3, respectively, for CTZNa 
)50(
)10()90(
d
ddSpan -=
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MPs and CTZNa NPMP. As both materials after spray drying were fully PXRD amorphous7,8, a slight 
decrease in the true density values in comparison to CTZNa ANH was not surprising, since 
amorphisation results in a decrease in true density in comparison to the crystalline material22. Particle 
size analysis by laser diffraction determined a monomodal particle size distribution with a median 
particle size of 2.6±0.1 µm and 2.9±0.0 µm for MPs and NPMPs, respectively. The TBET of NPMPs 
confirmed an increase in surface area of the material in comparison to CTZNa MPs, as was expected 
due to the porosity of the spray dried NPMP particles which was observed on SEM (Fig. 1a); TBET for 
the NPMP system was 72.32±0.71 m2/g, in contrast to a TBET of 1.32±0.04 m2/g for the smooth spheroidal 
particles of CTZNa MPs7. 
 
Fig. 1. SEM images of NPMP a) CTZNa5, b) CTZK5.   
 
The crystal structure of chlorothiazide potassium dihydrate (CTZK DH) and alternative solid 
state forms of the potassium salt, i.e. the monohydrate (CTZK MH) and the anhydrous form were 
previously described4. The true density of CTZK DH material was 1.887±0.003 g/cm3, which is close to 
the theoretical value calculated based on the single crystal X-ray diffraction data of 1.867 g/cm3. The 
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TBET of CTZK DH was 0.62±0.03 m2/g, while that of CTZK MH was measured to be 1.74±0.03 m2/g. 
The difference in surface area between the two hydrated states may be attributed to irregularities of 
morphology and empty voids formed due to the loss of crystal water. The anhydrous material, CTZK 
ANH, had a d0 of 1.881±0.003 g/cm3, a median particle size, d(50), of 9.7±0.2 µm and a TBET of 
1.30±0.02 m2/g. The TBET of CTZK MP, which comprised spheroidal microparticles with slightly 
crumpled surfaces7, was 1.33±0.01 m2/g and was ~70-times lower than that of the CTZK NPMP 
material (90.20±0.91 m2/g, Fig. 1b).  
Di-PacTM was selected as a comparator material in this study as it is a crystalline filler/binder 
used as a direct compression base6. Di-PacTM had the lowest measured TBET of the materials measured, at 
0.21±0.04 m2/g.  
In this work we sought to minimise the differences in particle size (reflected in the d(10) and 
d(50) values) among powders subjected to tabletability studies, such that the impact of solid state and 
morphological changes, as opposed to particle size could be evaluated. Particle size distribution was 
reported to have a limited impact on tensile strength of tablets made of sodium chloride and sucrose, 
where wide, narrow and bimodal particle distributions of particles with median particle size of about 
400 µm were investigated23. The particles of CTZ salts did not vary considerably in d(10) size values, 
ranging from 0.9 to 1.7 µm in comparison to 27 µm for Di-PacTM (Table 3). The range of d(50) was also 
narrow, from 2.6 to 9.7 µm versus 178 µm for Di-PacTM.  
 
3.2. Assessment of tabletability performance 
3.2.1. Tablet hardness (P) and tensile strength (σt) 
If the powder bed forming the tablet has good compactibility performance, it is expected that 
the desired hardness (P) of the tablet (here referred to as force to tensile failure19) will be reached using 
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relatively low compression pressure. Furthermore, the hardness of the tablet will not vary significantly 
under fluctuations of the preset compression pressure during processing, and the change of the tablet 
hardness will be responsive to the change of compression pressure. In contrast to the tablet hardness 
(P), which is directly related to tablet shape and size, the tensile strength (σt) may be compared for 
different tablet sizes and shapes19,20.  
As an example of compactibility performance of a pure pharmaceutical excipient designed for 
direct compression, Di-PacTM formed tablets at a compression pressure as low as 64 MPa, which had a 
hardness of 23.7 N. The hardness increased linearly with compression pressure at a rate of 1.12 N  
per 1 MPa6.  
Of the CTZNa systems studied, the material with the best compactibility performance in terms 
of tensile strength versus compression pressure was CTZNa NPMP (Fig. 2a). 
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Fig. 2. a) Tensile strength (σt) in relation to compression pressure for: CTZNa DH, CTZNa ANH, 
CTZNa MPs, CTZNA NPMP and Di-PacTM and b) for CTZK DH, MH and ANH, CTZK MP and CTZK 
NPMP. Error bars express standard deviation (SD) for comparison purposes. 
 
The corresponding profile of change of compression pressure versus tensile failure for this system is 
presented in the supporting information file (Fig. SI.1a). At a compression pressure of 21 MPa CTZNa 
NPMPs formed tablets with a σt of 0.62 MPa. For every unit increase of compression pressure, the σt 
value of the CTZNa NPMP material increased by 36 x 10-3 MPa, which was the greatest dependence of 
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σt on compression pressure for all CTZNa materials tested; this was compared to an increase in the σt 
value of 9.5 x 10-3 MPa for every unit increase in compression pressure for Di-PacTM. Other CTZNa 
materials did not undergo compaction at a compression pressure of 21 MPa. Attempts to compress 
these materials (other than NPMPs) under compression pressures lower than 21 MPa resulted in tablets 
falling apart upon ejection from the die. The σt at a compression pressure of 64 MPa for CTZNa DH 
was 1.08 MPa and was significantly (p<0.05) higher than the equivalent values recorded for Di-PacTM 
(0.47 MPa), CTZNa ANH (0.53 MPa) and CTZNa MPs (0.59 MPa). The σt versus compression 
pressure profiles for CTZNa tablets are similar to those of P versus compression pressure (Fig. SI.1a). 
The supporting information file Table SI.1 contains a compilation of all parameters of the tablets 
discussed below in relation to the compression pressure applied.  
As was previously observed for CTZ, spray drying from mixed solvent systems resulted in 
powders (i.e. NPMPs) with improved compactibility compared to micronised materials6. The fact that 
CTZNa DH showed a better compactibility performance than CTZNa ANH or CTZNa MPs may be 
ascribed to the presence of water molecules in the crystal lattice of CTZNa DH. A similar phenomenon 
was noted by Sun and Grant who investigated the impact of compaction pressure on the tensile strength 
of tablets of anhydrous and monohydrated p-hydroxybenzoic acid, and reported that water of 
crystallisation improves tableting properties of p-hydroxybenzoic acid24. Pande and Shangraw also 
reported a reduced compactibility performance of dehydrated β-cyclodextrin in comparison to the 
hydrated material13. In the current work, it was observed that, on average, the tensile strength of tablets 
made of CTZNa DH was greater than the tensile strength of tablets made of CTZNa ANH for tablets 
compressed at the same pressure.  
It is hypothesised here that the water molecules contained in the crystal lattice cause the 
particles of CTZNa DH powder to stick together upon the application of compression pressure, thus 
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producing tablets with a greater σt in comparison to those made of the dehydrated material (CTZNa 
ANH) in which only plastic deformation, crushing, interlocking or thermal fusion of molecules can 
occur. Based on the results of crystallographic studies and the fact that the PXRD pattern of 
compressed CTZNa DH did not change in comparison to the starting material, it was surmised that it 
was not the coordinated molecules of water, but the interstitial water that may be responsible for the 
better compactibility of CTZNa DH compared to the anhydrous form. This is supported by extensive 
studies involving dynamic vapour sorption of water and the impact of absorbed water on the PXRD 
pattern of CTZNa DH, as previously described3. 
CTZNa ANH and CTZNa MPs tablets had lower σt at respective compression pressures than 
tablets of CTZNa DH (Fig. 2a). It should be noted that the anhydrous and amorphous CTZNa system 
(CTZNa MP) prepared by spray drying compacted better than CTZNa ANH (i.e. the equivalent 
crystalline material). At a compression pressure of 128 MPa, tablets formed from CTZNa MPs had a 
tensile strength of 1.59 MPa, while the tablets made of CTZNa ANH material had a σt of only 1.17 
MPa. This improvement may be attributed to the change of the solid state form, since the MPs 
produced by spray drying were amorphous, but CTZNa ANH still contained a residual crystalline 
phase. This indicates that the presence of an amorphous phase may have more importance in terms of 
influencing tabletability performance over the small differences in TBET between tested materials.     
Analysis of the profiles of σt versus compression pressure for CTZK materials (Fig. 2b) allowed 
similar conclusions to be drawn to those made for the equivalent CTZNa systems with respect to 
tabletability; the best compactibility performance being demonstrated for the spray dried materials, 
CTZK NPMP and CTZK MP. The profiles of σt versus compression pressure for the CTZK systems 
were similar to those showing relationships between P and compression pressure which are presented 
in Fig. SI.1b (in the supplementary file). Tablets made of CTZK NPMP at 21 MPa compression 
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pressure had a slightly higher σt (0.86 MPa) than the equivalent CTZNa system (0.62 MPa). The σt 
increased to 2.58 MPa and 5.11 MPa, respectively, at 64 MPa and 128 MPa compression pressures for 
CTZK NPMP.  
Tablets made of CTZK MPs showed a similar change in σt with increasing compression 
pressure as the CTZK NPMP system, with σt increasing by 28.3 x 10-3 MPa and 39.6 x 10-3 MPa for 
every MPa increase in compression pressure, for the MP and NPMP system, respectively. The lowest 
change in σt with increasing compression pressure was found for tablets made of CTZK MH, with σt 
changing by 2.10 x 10-3 for every MPa increase in compression pressure. The tensile strength of this 
batch of tablets was in the range from 0.81 MPa to 1.13 MPa at compression pressures between 128 
MPa and 278 MPa. Amorphous CTZK MPs had better tabletability than CTZK DH, CTZK MH and 
CTZK ANH. Over a compression pressure range of 64-128 MPa, the change of σt for CTZNa MPs was 
smaller (from 0.59 to only 1.59 MPa) than for CTZK MPs (0.93 to 3.52 MPa). The change in the σt for 
CTZNa MPs was lower than for amorphous lactose15, while the values for CTZK MPs were in a 
comparable range. This may be attributed to the lower Tg of CTZK (~159 °C) compared to CTZNa 
(~192 °C)7. It may be hypothesised that at high pressures, under mechanical and thermal stress which 
occur upon compaction, in the small areas of contact points between amorphous particles, lower Tg 
materials will be more prone to fusion, resulting in better compactibility. Amorphous lactose has a 
relatively low Tg (~ 105 ˚C)25. Drying, and as a consequence dehydration, of glucose at high 
temperatures was reported to promote the formation of amorphous phases which were responsible for 
better compacting properties of processed glucose14. These conditions are similar to the conditions of 
production of amorphous and anhydrous CTZK MPs and CTZK ANH, where the temperature of final 
drying was higher (170 ˚C) than the Tg of CTZK (159 ˚C)7 which could result in a partial 
amorphisation of CTZK ANH.  
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No increase in the σt of compacts made of CTZK DH in comparison to those made of the 
anhydrous CTZK ANH form was seen. This may be a result of the presence of an amorphous content 
in CTZK ANH or it may be due to the lack of interstitial molecules of water in the crystal structure of 
CTZK DH4. The presence of interstitial water was related to a high tensile strength in the case of 
CTZNa DH tablets.  
The lowest change of σt in relation to compression pressure applied was observed for CTZK 
MH tablets and this may be related to two aspects. Firstly, it is unlikely that the water molecules in 
CTZK MH are placed interstitially4. The other factor is related to the reduced possibility of 
amorphisation of CTZK MH in comparison to anhydrous CTZK ANH form, as the drying temperature 
of CTZK DH resulting in the CTZK MH form is approximately 80 ˚C below the Tg of the amorphous 
form of CTZK. 
 
3.2.2 Tablet porosity (εt) and surface area (TBET) 
The porosity of the tablet (εt) is a relative measure of empty spaces in the volume of the tablet in 
relation to the true density (d0) of the compressed material. The density of a completely compressed 
tablet with 0% εt will be equal to the d0 of the powder that forms the tablet. Porosity is one of the 
measures of compressibility performance of the material under applied compression pressure1. 
The calculated εt of the CTZNa NPMP tablets at a compression pressure of 21 MPa was 64.51% 
(Fig. 3a); under a compression pressure of 64 MPa this decreased to 46.67% and reached 31.97% at 
128 MPa.  
 
 
 21 
 
 
 
Fig. 3. a) Porosity of the tablet (εt) in relation to compression pressure for: CTZNa DH, ANH, CTZNa 
MP, CTZNA NPMP and Di-PacTM, b) CTZK DH, MH and ANH, CTZK MP, CTZK NPMP compared 
to Di-PacTM. 
 
Over the range of compression pressures analysed, the εt of the NPMP tablets reduced by about 32.54% 
gaining 3.86 MPa in the tablet σt. The tablets made of nonporous materials tested over a range of 
compression pressure from 64 MPa to 214 MPa did not present such large variations in tablet porosity. 
Among the nonporous systems, the largest εt, of 33.5% at 64 MPa, was recorded for CTZNa MP 
tablets. CTZNa ANH and CTZNa DH tablets made at 64 MPa compression pressure had εt of 26.67% 
and 20.63%, respectively. CTZNa DH, CTZNa ANH and CTZNa MP materials had similar 
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responsiveness in terms of change in εt with increasing compression pressure, but the dihydrated 
material presented a much better performance in terms of the increase of tensile strength, which was 
similar to the NPMP system.     
The largest change of εt versus increasing compression pressure was recorded for the CTZK 
NPMP tablets (Fig. 3b). The change of εt was very similar to that of the equivalent CTZNa NPMP 
compacts. The CTZK NPMP tablets compressed at 21 MPa compression pressure had a εt of 62.79%. 
After the compression of the powder at 128 MPa the εt was reduced to 34.17%. In the tested range of 
compression pressures from 21 up to 128 MPa CTZK NPMP tablets lost 28.62% of εt, while the σt 
increased by 4.25 MPa. When analysing tablets of other CTZK materials, at 128 MPa compression 
pressure, the largest εt, of 32.07%, was recorded for the nonporous spray dried material (CTZK MPs). 
The εt of tablets made of CTZK ANH, CTZK MH and CTZK DH decreased with an increased degree 
of material hydration and was 24.31%, 21.13% and 18.71%, respectively. The same order was 
maintained at 214 MPa compression pressure. A reduction of εt, by only 0.07%, over the tested range of 
compression pressures from 128 to 278 MPa was recorded for CTZK MH material. This change in εt 
corresponded to a very small, but a statistically significant (p<0.05) change of tablet σt, of 0.32 MPa, 
indicating that this material presented the worst compactibility, regarding reduction of εt and increase of 
σt with the change of compression pressure, of all the powders tested.  
In comparison, over the range from 64 to 214 MPa compression pressure, the tablet porosity of 
Di-PacTM (Fig. 3a) decreased by about 8.38%, while the tablet tensile strength increased by about 1.33 
MPa. Compilation of the obtained results of εt and corresponding σt (Fig. 4) confirms the superior 
compactibility properties of anhydrous and amorphous CTZNa and CTZK NPMP systems compared to 
other materials examined.  
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Fig. 4. Porosity of the tablet in relation to tensile strength, for all tablets produced6. 
 
At each data point corresponding to a particular compression pressure, NPMP systems presented 
greater σt and εt when compared to the rest of the systems tested. Porosities of CTZK NPMP and 
CTZNa NPMP tablets (at a given compression pressure) are very similar; however CTZK NPMP 
tablets tend to have slightly higher σt values.   
The εt of NPMP tablets was seen to be reduced with increasing compression pressure and at 128 
MPa was close to values of εt for tablets made of non-porous materials, at about ~30%. The porosity of 
tablets may not reflect changes in the TBET of compressed materials. In order to evaluate changes of TBET 
of the compressed materials, tablets were subjected to BET analysis. It was hypothesised that this 
analysis would help to elucidate particular compaction mechanisms in the production of NPMP tablets. 
The mechanisms expected to enlarge TBET of the material are crushing and plastic deformation. The one 
mechanism, which will result in a reduction in TBET is fusion of particles into larger agglomerates. 
Interlocking of particles or elastic deformation under compression are considered as compaction 
mechanisms which do not have an impact on the TBET of the tablets7. Under increasing compression 
pressure the bed of powder placed in the die between the upper and lower punches starts to compact 
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firstly by migration of powder and interlocking7. Secondly, elastic deformation can occur with 
increasing compression pressure; this elastic deformation may transfer into a permanent change of 
particle shape, i.e. plastic deformation. A further increase of compression load may result in particle 
cracking and crushing, together with the same processes as those occurring at lower loads. Finally, 
under high compression pressure, smaller particles can merge (fuse) together into larger particles.  
The analysis of the TBET values of CTZNa ANH at the first compression pressure point revealed 
fusion of the material, as the TBET decreased from 3.07 m2/g (loose powder) to 2.61 m2/g (tablet 
compressed at 64 MPa compression pressure) (Fig. 5).  
 
 
 
Fig. 5. Specific surface area of the tablet (TBET) in relation to compression pressure for: a) CTZNa DH, 
CTZNa ANH, CTZNa MP and CTZNa NPMP, b) CTZK DH, MH and ANH MP, CTZK MP and 
CTZK NPMP. 
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This behaviour upon compression may be ascribed to the layered (foliated) structure of CTZNa ANH 
particles, seen on SEM pictures (Fig. 6c), similar to slate rock. Foliation of particles of the CTZNa DH 
form was not observed (Fig. 6a).  
 
 
Fig. 6. SEM images of: a) morphology of CTZNa DH, b) cross section of the tablet made of CTZNa 
DH compressed at 128 MPa, c) morphology of CTZNa ANH, d) cross section of the tablet made of 
CTZNa ANH compressed at 128 MPa with an insert depicting the crystal lattice packing of CTZNa 
DH, e) and f) cross section of the tablet made of CTZNa NPMP compressed at 128 MPa. Red circles 
indicate occurrence of foliation in CTZNa ANH possibly related to evaporation of water from CTZNa 
DH crystal structure (in inset).  
 
Foliation may be ascribed to evaporation of water molecules layered along the a axis in the crystal 
structure of CTZNa DH1. The reduction of TBET at the initial compression pressure of 64 MPa may be 
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assigned to compression of the crystal lattice of CTZNa ANH.  At a compression pressure of 128 MPa 
TBET increased in comparison to that of the loose powder, to 3.4 m2/g, indicating the possibility of 
cracking (Fig. 6b) of particles, and then slightly dropped to 3.16 m2/g at a compression pressure of 214 
MPa, where particles may have started to fuse.  
In contrast to CTZNa ANH, CTZNa DH showed a constant drop of TBET from the value 
presented for the loose powder (2.69 m2/g) to 0.89 m2/g at the compression pressure of 64 MPa and to 
0.7 m2/g at the compression pressure of 278 MPa. This indicated that particles of this system fused 
together very easily even at low compression pressure, possibly due to the release of molecules of 
interstitial crystal water, as discussed above. The change in the TBET values of tablets made of CTZNa 
MPs was similar to that recorded previously for CTZ NPMP, where firstly particles started to crack and 
break, increasing TBET slightly, a plateau was reached between 64 and 128 MPa and then the TBET dropped 
at 214 MPa compression pressure suggesting fusion of particles6. TBET reduction under increasing 
compression pressure recorded for the CTZNa NPMP indicated that particles of this system compacted 
predominantly due to the fusion of particles, regardless of the compaction pressure.   
In the compression pressure range of 21 MPa to 128 MPa, the reduction in TBET versus 
compression pressure for the CTZK NPMP tablets was approximately linear and similar in behaviour 
to the CTZNa NPMPs. The change in TBET for CTZK MH and CTZK MPs tablets on rising compression 
pressure was very low, indicating that these systems were compacted predominantly due to elastic 
deformation and interlocking. CTZK ANH material behaved similarly to Di-PacTM, but differently to the 
equivalent CTZNa ANH system. CTZK ANH did not present a TBET drop at the initial compression 
pressure, which may be ascribed to the different crystal structure of the hydrate, where, in contrast to 
CTZNa, chlorine atoms of CTZ are involved in direct coordination bonds with the potassium cation, as 
was presented previously2, which may prevent foliation, as described for CTZNa ANH.     
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Comparisons of the TBET values with porosity data (Fig. 7 a) of the tablets for all systems tested 
indicated that the CTZK and CTZNa NPMP materials formed highly-porous tablets with large TBET. The 
high porosity could be visualised by SEM (Fig. 6f). 
 
 
Fig. 7. Specific surface area of the tablet (TBET) versus: a) tablet porosity (εt) and versus: b) tablet tensile 
strength (σt). 
 
NPMP tablets, despite undergoing compression and reaching porosities comparable to those 
determined for tablets made of non-NPMP materials, still preserved relatively high TBET. Furthermore, 
the NPMP tablets had the greatest mechanical strengths, as seen from the TBET versus σt plots (Fig. 7b). 
The σt of NPMP tablets was comparable or higher than the σt of tablets made from conventionally 
produced materials at similar TBET values.  
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Overall, tablets made of NPMPs were characterised by the best compactibility. These tablets 
presented the highest σt at low compression pressure compared to other tablets. The highest σt 
corresponded with the highest εt and the highest TBET of the material in the tablet form after compression. 
In the study of Sebhatu and Alderborn on relationships between the effective interparticulate contact 
area and the σt of tablets made of amorphous and crystalline lactose, the εt made of the amorphous 
material was similar to that made of crystalline lactose and was ~30% at a compression pressure of 75 
MPa and decreased to ~20% at 125 MPa (0.2%/MPa)13. For the amorphous systems the decrease in εt 
corresponded with an increase in the σt from 0.5 MPa to approximately 3 MPa, while the σt of tablets 
made of crystalline lactose increased only in a range from 0.2 to nearly 1 MPa. In comparison, the εt of 
the CTZNa and CTZK NPMP materials varied in this compression pressure range from ~47% to ~32%. 
These higher values of εt in comparison to the reported lactose tablets corresponded to a greater change 
and range of σt from 2.2 MPa to as high as 5.1 MPa.  
In the study of Westermarck et al. the pore structure and TBET of tablets made of mannitol powder 
and processed granulate were compared15. The εt of mannitol powder tablets decreased from 21% to 
14% over a compression pressure range from 72 up to 196 MPa. The decrease of εt corresponded to an 
increase in TBET of the tablet from 0.58 to 0.61 m2/g in comparison to the initial TBET of the powder of 0.34 
m2/g. The reported increase of TBET for mannitol tablets was similar to that observed for CTZK ANH 
tablets, ascribed to the mechanism of brittle fracture of particles with rising compression pressure. The 
reduction of εt (26%-17%) for tablets made of mannitol granulate, in contrast to tablets made of the 
mannitol powder, corresponded to a reduction in the TBET of the material from 1.55 to 1.26 m2/g. This 
decrease in TBET, also observed for the tablets made of NPMPs and CTZNa DH, was ascribed to the 
mechanism of fusion of particles with rising compression pressure.  
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Studying the compaction behaviour of lactose, Busignies et al. observed the TBET of lactose to initially 
increase and to then decline with rising compression pressure in a similar manner to that observed for 
CTZNa MPs and CTZNa ANH tablets, indicating that the initial mechanism of compaction was plastic 
deformation and/or ductile fraction and secondly the predominant mechanism of compaction was 
fusion of particles18. 
 
3.3. Dissolution studies 
It was postulated that the large TBET of the NPMP powders preserved in the compacted tablets and the 
porosity of the tablets may promote faster dissolution of NPMP tablets, compared to tablets made of 
non-porous materials. The tablets selected for dissolution studies were those compressed at the same 
compression pressure of 128 MPa (Fig 8 a and c), as some of the materials did not undergo 
compression at lower compression pressures. Additionally, NPMP tablets investigated were also 
compressed at compression pressures of 64 MPa and 21 MPa (Fig. 8 b and d).  
It should be noted that all dissolution studies were performed in sufficient dissolution medium 
to ensure sink conditions and disintegration under dissolution conditions was not observed for any of 
the tablets tested.  
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Fig. 8. Dissolution profiles (n≥3) of: a) all CTZNa tablets compressed at compression pressure (CP) of 
128 MPa, b) CTZNa NPMPs tablets compressed respectively at compression pressures of 21 MPa, 64 
MPa and 128 MPa, c) all CTZK tablets compressed at compression pressure of 128 MPa and d) 
CTZNa NPMPs tablets compressed respectively at compression pressures of 21 MPa, 64 MPa and 128 
MPa.  
 
For CTZNa materials, the fastest dissolution of API was recorded for tablets made of NPMPs 
compressed at 21 MPa (Fig. 8 a). The σt of these tablets was 0.62 MPa, with a εt of 64.5% which 
corresponded to a tablet TBET of 64.7 m2/g. 100% of the 250 mg of API was dissolved between the third 
and fourth minute of the experiment. CTZNa NPMP tablets compressed at 64 MPa performed nearly as 
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well, though the standard deviations of the dissolution profile points was higher. Tablets compacted at 
128 MPa had higher standard deviation (SD), ~0.6 MPa, for tablet tensile strength (4.48 MPa) than 
tablets compressed at lower compression pressures, indicating increased variation in tensile strength. 
This finding was found to correspond to increased SD in the concentration time-points of dissolution 
profiles. Tablets made of CTZNa NPMP prepared at a compression pressure of 128 MPa fully 
dissolved after 12 minutes, 7 minutes faster than CTZNa MP tablets (19 minutes). The performance of 
tablets made of CTZNa DH was similar to that of CTZNa MP tablets.  
The CTZNa DH tablets performed better than those made of CTZNa ANH even though the 
latter tablets had a larger TBET and εt and lower σt (SI, Table SI.1). The lower dissolution rate of CTZNa 
ANH can be associated with hydration and recrystallisation of CTZNa ANH to CTZNa DH, as 
observed by PXRD and which occurred on the tablet surface during dissolution. Similarly, lower 
dissolution rates, in comparison to tablets made of hydrated theophylline, were previously observed for 
anhydrous theophylline tablets26. This was ascribed to hydration of theophylline upon dissolution study. 
In the case of CTZNa ANH, 100% API was dissolved after only 30 minutes.  
In the case of CTZK (Fig. 8b), the best dissolution performance was observed again for tablets 
made of CTZK NPMPs. As for CTZNa tablets, the tablet dissolution performance deteriorated with 
increasing compression pressure from 21 MPa to 128 MPa. The respective times taken to fully dissolve 
the tablets made of CTZK NPMPs were 6 min (σt of 0.86±0.24 MPa), 9 min (σt of 2.58±0.51 MPa) and 
19 min (σt of 5.11±0.81 MPa). In comparison to the tablets of CTZK NPMP, the variation of the 
dissolution profile of CTZK DH tablets was smaller, which may be attributed to smaller deviations in σt 
(1.34±0.34 MPa). CTZK ANH tablets were found to dissolve slower than CTZK DH, perhaps due to 
CTZK hydration, as was seen for CTZNa. 
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CTZK ANH tablets had larger σt than CTZK MH tablets and nearly 10% lower εt, but 
compressed CTZK ANH had a TBET (2.07 m2/g) twice that of CTZK MH (1.23 m2/g). Despite the 
differences, CTZK ANH and CTZK MH tablets fully dissolved within 30 minutes, 10 minutes slower 
than CTZK DH and CTZK NPMP tablets. The slowest dissolution was recorded for tablets made of 
CTZK MPs, which were characterised by low σt (0.93 MPa), relatively high εt (32%) and TBET of about 
1.23 m2/g. It was observed, that for this system only about 50% of the API was dissolved up to the 30th 
minute.  
Since the solubilities of the dihydrated salts of CTZK and CTZNa are both close to 80 mg/ml3,4, 
depicted differences in dissolution profiles can be attributed to the tablet characteristics. Amorphous, 
anhydrous or monohydrated forms of salts are unstable in an aqueous environment and will tend to 
rapidly convert to dihydrated forms which are stable in water. Direct “in situ” control of surface solid-
phase transformation during dissolution experiments was not performed. 
In this work, tablets with the largest TBET had the fastest dissolution rates. Jaleel et al. formulated 
orally dispersible tablets containing loratadine from a solid dispersion with PVP K30 (1:3 w/w ratio, 
loratadine dose of 10 mg)26. Dissolution studies were performed at a higher rate of paddle rotation of 
100 rpm than that used in this work. The tablets, considered as orally dispersible (ODTs) formulations, 
containing the superdisintegrant (Crospovidone- polyplasdone XL-10, polyplasdone XL) released the 
whole dose of loratadine after the 3rd minute and those without the superdisintegrant after the 5th minute. 
The results suggest that the API materials formulated as NPMPs may be considered as suitable to be 
formulated into ODT systems. Further studies will be undertaken to develop such formulations. 
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4. Conclusions 
Nanoparticulate microparticles (NPMP) of amorphous, anhydrous materials produced by spray 
drying had better tabletability performance in comparison to conventionally processed materials, as 
seen from single point measures of force to tensile failure (P), tensile strength (σt) and tablet porosity 
(εt) versus compression pressure used to compact material. The tablets made of NPMPs presented 
higher σt and higher εt than those made of crystalline, non-porous spray dried material or material 
designed for direct compaction (Di-PacTM). The NPMP compacts partially retained large specific surface 
area (TBET) of the starting powders, at the same time presenting large εt and satisfactory σt.  
This study indicated that, in terms of defining the tabletability performance of compressed materials, 
neither particle size nor particle size distribution were critical parameters. For example, particles of the 
same material, such as amorphous CTZNa NPMPs and CTZNa MPs, which both had monomodal 
particle size distributions, very similar span values as well as very comparable d(10), d(50) and d(90) 
parameters presented very different tabletability profiles. 
Salt (CTZNa and CTZK) NPMP tablets presented very good dissolution test performance indicating 
that NPMP materials may be considered as suitable for direct compaction and possibly for inclusion in 
tablet formulations as bulking agents, APIs, carriers or binders due to their good compactibility 
performance.  
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